-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Biological, Coronaviruses, CRS, Follicular Lymphoma, SARS-CoV-2/COVID-19, survivorship, therapy sequence, Diseases, Lymphoma (any), neurotoxicity, Non-Biological, CAR-Ts, Combinations, Elderly, Therapies, Adverse Events, checkpoint inhibitors, chemotherapy, CNS Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, DLBCL, enzyme inhibitors, Technology and Procedures, immunotherapy, Lymphoid Malignancies, Study Population, Clinically relevant, imaging, pharmacology, Proliferative disorders, Quality Improvement
Monday, December 7, 2020: 7:00 AM-3:30 PM

Edward Bataillard1,2*, Will Harris3*, Tarec Christoffer El-Galaly4, Antonia Kwan3*, Carsten Henneges3*, Joseph N Paulson3* and Tina G Nielsen4*

1Imperial College Healthcare NHS Trust, London, United Kingdom
2On assignment to Roche Products Ltd, Welwyn Garden City, United Kingdom
3Genentech, Inc., South San Francisco, CA
4F. Hoffmann-La Roche Ltd, Basel, Switzerland

Guilherme Fleury Perini, MD1*, Juan Alejandro Ospina Idarraga2*, Maria Alejandra Torres Viera, MD3*, Brady E Beltran, MD4,5*, Denisse A. Castro, MD6,7, Victoria Otero, MD8*, Mariana Kalmus9*, Lorena Fiad, MD10*, Camila Peña, MD11, Henry Idrobo, MD12,13*, Myrna Candelaria, MD, PharmD14, Alana Von Glasenapp, MD15*, Ivan Perdomo, MD16*, Carolina Feres, MD1*, Maria Prates, MD17, Sally Rose Paredes, MD6,18*, Fernando Pérez-Jacobo, MD19, Ana Ramirez-Ibarguen, MD20*, Claudia Gajardo, MD21*, Macarena Alejandra Roa Salinas22*, Humberto Martínez Cordero, MD23*, Melani Otañez, MD24*, Fabiola Valvert, MD25, Efreen Montaño Figueroa, MD, PhD26*, Marcos Di Stefano, MD27*, Rosio Baena, MD28*, Juan Antonio Choque, MD29*, Virginia Abello, MD30*, Ximena Valladares, MD21*, Sofia Sanchez, MD31*, Cristaldo Nancy, MD32*, Daniela Zambrano33*, Juan Felipe Lasso, MD34*, Andrea Noboa, MD35*, Christine Rojas, MD36*, Larissa LC Teixeira37*, Luis Malpica Castillo, MD38*, Eduardo Sotomayor, MD39, Jorge J. Castillo, MD40 and Luis Villela Villela, MD, MC41*

1Hospital Israelita Albert Einstein, São Paulo, Brazil
2Instituto Nacional de Cancerología, Bogotá, Colombia
3Clinica Santa Sofia, Caracas, Miranda, Venezuela
44Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
5Departamento de Oncología y Radioterapia,, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
6Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
7Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
8Sección Hematología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
9Clinica Olivos, Buenos Aires, Argentina
10Hematología, Hospital Italiano de La Plata, La Plata, Argentina
11Hematology Department, Hospital Del Salvador, Santiago, Chile
12Hematología Oncología, Grupo Ospedale, Cali, Colombia
13Facultad de Medicina., Universidad Del Valle, Cali, Colombia
14Research Division, Instituto Nacional de Cancerología, Mexico City, Mexico
15Department of Hematology, Instituto de Prevision Social, Asuncion, Paraguay
16Clínica Los Nogales, Bogota, Colombia
17Hematology, Hospital Italiano La Plata, La Plata, Argentina
18Centro de Investigacion de Medicina de Precision, Universidad de San Martin de Porres, Lima, Peru
19Hematology Department, Hospital Central Norte Petróleos Mexicanos, Ciudad DE Mexico, Cdmx, Mexico
20Instituto Nacional de Cancerologia, Mexico, Mexico
21Hospital del Salvador, Santiago, Chile
22Hematología, Hospital Del Salvador, Santiago, Chile
23Instituto Nacional de Cancerologia, Bogota, Bogota, Colombia
24Hematology, Hospital General del Estado, Hermosillo, SO, Mexico
25Instituto De Cancerología y Hospital Dr. Bernardo Del Valle (INCAN), Ciudad de Guatemala, Guatemala
26Hospital General de México, SSA, mexico, EM, Mexico
27Hospital de Clínicas Caracas, Caracas, Venezuela (Bolivarian Republic of)
28Instituto Oncológico Nacional Caja Petrolera de Salud, Cochabamba, Bolivia
29Servicio de Hematologia, Caja Nacional de Salud - Hospital de Especialidades Materno Infantil La Paz, La Paz, La Paz, Bolivia
30Hospital de San José. Fundación Universitaria de Ciencias de la Salud (FUCS), Bogota D.C, Colombia, Colombia
31Hospital La Raza IMSS, Mexico City, Mexico
32Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina
33Hospital Del Salvador, Santiago, Chile
34Fundación Universitaria San Martín, Cali, Colombia
35Servicio de Hematologia, Instituto Oncológico Nacional Dr. Juan Tanca Marengo, Guayaquil, Ecuador
36Hospital Gustavo Frieke, Viña del Mar, Chile
37Hospital Israelita Albert Einstein, Sao Paulo, Brazil
38The University of Texas MD Anderson Cancer Center, Houston, TX
39George Washington University Cancer Center, Washington, DC
40Bing Center for Waldenström Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA
41Campus Hermosillo, Universidad del Valle de Mexico, Hermosillo, Mexico

Stephen Boyle1,2*, Joshua W.D. Tobin, MD2,3*, Jacinta Perram, MBBS, BSc, MPH, BA4, Nada Hamad, MBBS, BSc, MSc, FRACP FRCPA5, Allison Barraclough, MBBS FRACP FRCPA6*, Lydia Singaraveloo7*, Min-Hi Han, MBBS, BSc8*, Richard Blennerhassett9,10*, Niles Elizabeth Nelson, BSc, MBBS11*, Anna Johnston, MBBS (Hons 1), FRACP, FRCPA12,13*, Dipti Talaulikar, PhD, FRACP, FRCPA, MBBS14,15, Krishna Karpe16*, Abir Bhattacharyya, MBBS, FRACP, FRCPA9*, Chan Yoon Cheah, MBBS8,17, Elango Subramoniapillai, MBBS, FRACP18,19*, Waqas Bokhari18*, Cindy Lee, MD20*, Eliza A Hawkes, FRACP, MD, MBBS21,22,23, Veena Gullapalli, MBBS FRACP FRCPA24, Andrew Jabbour25*, Simone Strasser, MBBS MD FRACP FAASLD10,26*, Steve Chadban, BMed(hons), PhD, FRACP, FAHMS10,27*, Christina Brown, MBBS PhD FRACP FRCPA10,28, Peter Mollee, FRACP, MBBS, MSc, FRCPA1,2 and Greg Hapgood, BMBS, FRACP, FRCPA1,2

1Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
2University of Queensland, Brisbane, QLD, Australia
3Department of Haematology, Gold Coast University Hospital, Gold Coast, QLD, Australia
4Royal Prince Alfred and Concord Hospitals, Sydney, Camperdown, AUS
5Department of Haematology, St Vincent's Hospital, Sydney, Australia
6Olivia Newton John Cancer Research Institute, The Austin Hospital, Melbourne, VIC, Australia
7Royal Adelaide Hospital & The Queen Elizabeth Hospital, Adelaide, SA, Australia
8Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
9Dept of Haematology, Westmead Hospital, Sydney, NSW, Australia
10University of Sydney, Sydney, NSW, Australia
11Department of Hematology, Royal Hobart Hospital, Hobart, Australia
12Department of Haematology, Royal Hobart Hospital, Hobart, Australia
13University of Tasmania, Hobart, Australia
14Medical School, The Australian National University, Canberra, Australia
15Department of Haematology, The Canberra Hospital, Canberra, Australia
16Dept of Renal Medicine, Canberra Hospital, Canberra, ACT, Australia
17University of Western Australia, Crawley, WA, Australia
18Department of Haematology, Royal Brisbane Hospital, Brisbane, QLD, Australia
19The Prince Charles Hospital, Brisbane, QLD, Australia
20Department of Haematology, Royal Adelaide Hospital & The Queen Elizabeth Hospital, Adelaide, SA, Australia
21Dept of Haematology & Medical Oncology, Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, Australia
22Eastern Health, Box Hill, VIC, Australia
23University of Melbourne, Melbourne, VIC, Australia
24Dept of Haematology, St Vincent’s Hospital, Sydney, NSW, Australia
25Dept of Cardiology, St Vincent’s Hospital, Sydney, NSW, Australia
26AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia
27Kidney Node, Charles Perkins Centre & Royal Prince Alfred Hospital, Sydney, NSW, Australia
28Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia

Lindsey Fitzgerald, MD1, Adam S. Kittai, MD2, Loretta J. Nastoupil, MD3, Alexandra Waller4*, Caron Jacobson, MD, MMSc5, Anna Saucier6*, Nathan Denlinger, MS, DO7, Manali Kamdar, MD8, Janet Spradley9*, Ryan C. Lynch, MD10*, Jonathan Chipman11* and Boyu Hu, MD11*

1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
2Division of Hematology, The Ohio State University, Columbus, OH
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Dana Faber Cancer Institute, Harvard Medical School, Boston, MA
6Dana Farber Cancer Institute, Boston, MA
7Ohio State University Wexner Medical Center, Columbus, OH
8Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO
9University of Colorado School of Medicine, Aurora, CO
10University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
11Huntsman Cancer Institute-University of Utah, Salt Lake City, UT

Rachel Brown, MD1*, Alessandro Lambertini, MD2*, Michael S Hofman, MBBS (Hons), FRACP, FAANMS2*, Mathias Bressel, M.Sc2*, Michael P Macmanus, MD, MRCP, MBBS2*, Andrew Wirth, MBBS, MD, FRACP, FRANZCR2*, John F. Seymour, MBBS3, Michael Dickinson, MBBS, FRACP, FRCPA2 and Belinda Campbell, MBBS, MMed, FRANZCR2*

1Royal Melbourne Hospital, North Melbourne, VIC, Australia
2Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
3Peter Maccallum Cancer Centre, Melbourne, VIC, Australia

Karin Ekstroem Smedby1,2*, Sara Harrysson, MD2,3*, Sara Ekberg2*, Mats Jerkeman, MD, PhD4, Per-Ola Andersson, MD, PhD5,6*, Gunilla Enblad7,8* and Sandra Eloranta9*

1Dept of Hematology, Karolinska University Hospital, Stockholm, Sweden
2Division of Clinical Epidemiology, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
3Dept of Hematology, Karolinska University Hospital, Solna, Sweden
4Department of Oncology, Lund University and Skane University Hospital, Lund, Sweden
5Gothenburg University, Sahlgrenska Academy, Gothenburg, Sweden
6Dept of Hematology, South Älvsborg Hospital, Borås, Sweden
7Dept of Oncology, Akademiska University Hospital, Uppsala, Sweden
8Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
9Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Geoffrey Shouse, DO, PhD1, Thai Cao, MD2*, Jianying Zhang3*, Matthew Mei, MD2, Alex F. Herrera, MD2, Liana Nikolaenko, MD2, Jasmine Zain, MD2, Tanya Siddiqi, MD4, Leslie L. Popplewell, MD, FACP5, Stephen J. Forman, MD2 and Lihua E Budde, MD, PhD6

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
3Division of Biostastics, City of Hope National Medical Center, Duarte, CA
4Department of Hematology/HCT, City of Hope, Duarte, CA
5Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
6T Cell Therapeutics Research Laboratory, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Felipe Castro1*, Andy Surinach, MPH2*, Aino Launonen1*, Per-Olof Thuresson1* and Federico Felizzi1*

1F. Hoffmann-La Roche Ltd, Basel, Switzerland
2Genesis Research, Hoboken, NJ

Devi Sampat, MD1 and Gaurav Goyal, MD2

1University of Alabama at Birmingham (UAB), Birmingham, AL
2University of Alabama at Birmingham, Birmingham, AL

Marie-Charlotte Laude1*, Edith Julia2*, Emmanuelle Nicolas-Virelizier, MD3*, Gabriel Antherieu2*, Violaine Safar4*, Philippe Rey, MD3*, Emmanuelle Ferrant, MD2*, Alexandra Traverse-Glehen, MD, PhD5*, Catherine Chassagne-Clément, MD6*, David Meyronet, MD, PhD7*, Anne Lazareth, MD2*, Helene Lequeu, MD2*, Camille Golfier, MD2*, Gabriel Brisou, MD2*, Dana Ghergus, MD2*, Pierre Sesques, MD2*, Lionel Karlin, MD2*, Gilles Salles, MD, PhD2, Emmanuel Bachy, MD, PhD2*, François Ducray, MD, PhD8*, Fadhela Bouafia, MD2*, Youenn Drouet, PhD9* and Herve Ghesquieres, MD, PhD2*

1Department of Hematology, Lyon-Sud Hospital, Pierre Bénite, France
2Department of Hematology, Lyon-Sud Hospital, Pierre-Benite, France
3Hematology, Centre Leon Berard, Lyon, France
4Centre Hospitalier Lyon-Sud, Lyon, France
5Department of Pathology, Lyon-Sud Hospital, Pierre-Benite, France
6Department of Pathology, Leon Berard Center, Lyon, France
7Department of Pathology, Neurology Hospital, Bron, France
8Department of Neurology, Neurology Hospital, Bron, France
9Department of Statistics, Leon Berard Center, Lyon, France

Angel Mier-Hicks, MD1, Adrienne Groman, MS2*, Kristopher Attwood, PhD2*, Shalin K. Kothari, MD1, Caroline Kumm, MS, CCRC1*, Suchitra Sundaram, MD1, Francisco J. Hernandez-Ilizaliturri, MD3 and Pallawi Torka, MD1*

1Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY

Sushanth Gouni, MD1*, Paolo Strati, MD2, Jason Westin, MD3, Loretta J. Nastoupil, MD4, Raphael E Steiner, MD5, Ranjit Nair, MD6, Luis Fayad7, Sattva S. Neelapu, MD3, Ralf Landgraf, PhD8*, Daniel Bilbao, PhD9, Francisco Vega, MD, PhD10 and Nitin Agarwal, PhD11*

1University Of Texas Health Science Center at Houston, Houston, TX
2Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
6Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
8Department of Biochemistry and Molecular Biology, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL
9Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
10Hematopathology, MD Anderson Cancer Center, Houston, TX
11MD Anderson Cancer Center, Houston, TX

Cesar Gentille Sanchez, MD1, Ethan Burns, MD1*, Ibrahim Muhsen, MD2*, Humaira Sarfraz, MD2*, Carlo Guerrero, MD1*, Jasleen K. Randhawa, MD3, Shilpan S. Shah, MD1, Joe Ensor, PhD4* and Sai Ravi Kiran Pingali, MD1

1Houston Methodist Cancer Center, Houston, TX
2Department of Internal Medicine, Houston Methodist Hospital, Houston, TX
3Houston Methodist Cancer Center, Houston
4Houston Methodist Research Institute, Houston, TX

Lorena Panaite, MBBS1, Jordan Gauthier, MD2,3, Paula Perkins, MS, PA-C4*, Jenna Voutsinas, MPH4*, Qian Vicky Wu, PhD4,5,6*, Angela Kirk, PA-C7*, Aisling Cearley, PA-C4*, Erin Mullane, DNP8,9*, Ryan D. Cassaday, MD1,3,8, Hans-Peter Kiem, MD, PhD10,11, Victor A. Chow, MD3,8,12, Ryan C. Lynch, MD4,8,12, Chaitra S. Ujjani, MD13, Stephen D. Smith, MD14, Ajay K. Gopal, MD3,8,15, Brian G. Till, MD3,8,12, Cameron J. Turtle, MBBS, PhD1,8,16, David G. Maloney, MD, PhD4,17 and Mazyar Shadman, MD1,3,8

1Department of Medicine, University of Washington, Seattle, WA
2University of Washington, Seattle Cancer Care Alliance, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Fred Hutchinson Cancer Research Center, Seattle, WA
5Fred Hutchinson Cancer Research Center, Department of Clinical Biostatistics, Seattle, WA
6Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA
71100 Fairview Ave N, Fred Hutchinson Cancer Research Center, Seattle, WA
8Seattle Cancer Care Alliance, Seattle, WA
9Fred Hutchinson Cancer Research Center, Seattle
10Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA
11Department of Pathology, University of Washington School of Medicine, Seattle, WA
12Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
13Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, WA
14University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
15Department of Medicine, Division of Medical Oncology, The University of Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Lymphoma Program, Seattle Cancer Care Alliance, Seattle, WA
16Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA
17University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA

Yazan Samhouri, MD1, Moaath Mustafa Ali, MD, MPH2*, Thejus Jayakrishnan, MBBS3, Chelsea Peterson, DO4*, Veli Bakalov, MD5, Salman Fazal, MD1, Cyrus Kahn, MD1*, Rodney E Wegner, MD6* and John Lister, MD1

1Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
2Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
3Department of Internal Medicine, Allegheny Helath Network, Pittsburgh, PA
4Department of Internal Medicine, Allegheny Health Network, Pittsburgh, PA
5Allegheny Health Network Cancer Institute, Pittsburgh, PA
6Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA

Sarah J. Rockwell, BS, PharmD1*, Katherine A. Richter, PharmD, MBA, BCOP1*, Ryan J. Caddell, PharmD, BCOP1* and Julio C. Chavez, MD2

1Department of Pharmacy, H. Lee Moffitt Cancer Center, Tampa, FL
2Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL

Prashasti Agrawal1*, Kevin A. David, MD 2, Zhengming Chen, PhD, MPH, MS3*, Suchitra Sundaram, MD4*, Seo-Hyun Kim, MD5, Ryan Vaca, MD6, Yong Lin, PhD7*, Samuel Singer, MD8*, Mary-Kate Malecek, MD9, Jordan Carter, MD7*, Adam Zayac, MD10, Myung Sun Kim, MD11*, Nishitha Reddy, MD12, Alma Habib, MD13*, Christopher Strouse, MD14, Jerome Graber, MD15*, Veronika Bachanova, MD, PhD16, Mazie Tsang, MD17, Ajay Major, MD, MBA18, David A. Bond, MD, BS19, Angel Mier-Hicks, MD20, Pallawi Torka, MD4*, Priya Rajakumar, MD21*, Parameswaran Venugopal, MD22, Michael Glantz, MD, PhD23*, Samuel Goldlust, MD24*, Rahul Matnani, MD25*, Pallavi Kumar, MD26*, Thomas A Ollila, MD27, Johnny Cai, DO28*, Stephen E. Spurgeon, MD29, Alex G Sieg, MD, MS30*, Joseph Cleveland, MD31*, Narendranath Epperla, MD, MS32, Reem Karmali, MD, MSc33, Seema Naik, MD34*, Sonali M. Smith, MD35, James L. Rubenstein, MD, PhD17, Brad S. Kahl, MD36, Amy Chadburn, MD37, Andrew M. Evens, DO, MMSc38 and Peter Martin, FRCPC, MD, MS39

1Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
2Cancer Institute of New Jersey, New Brunswick, NJ
3Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY
4Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
5Rush University Medical Center, Chicago, IL
6Penn State Cancer Institute, Penn State University College of Medicine, Hershey, PA
7Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
8John Theurer Cancer Center, Hackensack, NJ
9Department of Medicine, Washington University School of Medicine, University City, MO
10Department of Medicine, Alpert Medical School of Brown University, Providence, RI
11Knight Cancer Institute, Oregon Health and Science University, Portland, OR
12Vanderbilt University Medical Center, Nashville, TN
13University of Minnesota School of Medicine, Minneapolis, MN
14Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
15University of Washington, Seattle, WA
16Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
17Hematology/Oncology, UCSF, San Francisco, CA
18Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
19Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
20Roswell Park Comprehensive Cancer Center, Buffalo, NY
21Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL
22Division of Hematology Oncology, Rush University Medical Center, Chicago, IL
23Department of Neurosurgery, Penn State College of Medicine, Hershey, PA
24John Theurer Cancer Center, Hackensack-Meridian Health, Hackensack, NJ
25Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
26Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
27Brown University, Providence, RI
28Oregon Health and Science University, Portland, OR
29Oregon Health & Science University, Portland, OR
30Department of Internal Medicine, University of Iowa, Iowa City, IA
31University of California, San Francisco, San Francisco, CA
32Marshfield Clinic, Columbus, OH
33Division of Hematology Oncology, Northwestern University, Chicago, IL
34Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA
35Department of Oncology, University of Chicago, Chicago, IL
36Washington University School of Medicine in St. Louis, Saint Louis, MO
37Weill Cornell Medicine, New York, NY
38Rutgers Cancer Institute of New Jersey, Warren, NJ
39Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY

Gabriel Antherieu, PhD1*, Edith Julia2*, Emmanuelle Nicolas-Virelizier, MD3*, Marie-Charlotte Laude4*, Violaine Safar2*, Philippe Rey, MD3*, Emmanuelle Ferrant, MD2*, Alexandra Traverse-Glehen, MD, PhD5*, Catherine Chassagne-Clément, MD6*, David Meyronet, MD, PhD7*, Anne Lazareth, MD2*, Helene Lequeu, MD2*, Camille Golfier, MD2*, Gabriel Brisou, MD2*, Dana Ghergus, MD2*, Pierre Sesques, MD2*, Lionel Karlin, MD2*, Fadhela Bouafia, MD2*, Gilles Salles, MD, PhD2, Emmanuel Bachy, MD, PhD2*, François Ducray, MD, PhD8*, Youenn Drouet, PhD9* and Herve Ghesquieres, MD, PhD2*

1Department of Hematology, Lyon-Sud Hospital, Pierre Benite, France
2Department of Hematology, Lyon-Sud Hospital, Pierre-Benite, France
3Hematology, Centre Leon Berard, Lyon, France
4Department of Hematology, Lyon-Sud Hospital, Pierre Bénite, France
5Department of Pathology, Lyon-Sud Hospital, Pierre-Benite, France
6Department of Pathology, Leon Berard Center, Lyon, France
7Department of Pathology, Neurology Hospital, Bron, France
8Department of Neurology, Neurology Hospital, Bron, France
9Department of Statistics, Leon Berard Center, Lyon, France

Hua-Jay J Cherng, MD1, Raphael E Steiner, MD2, Luis Fayad3, Paolo Strati, MD4, Ranjit Nair, MD5, F. B. B. Hagemeister, MD5, Loretta J. Nastoupil, MD6, Hun Ju Lee, MD7, Sattva S. Neelapu, MD7, Christopher Flowers, MD, MS7, Felipe Samaniego, MD7, Maria Alma Rodriguez, MD7*, Lei Feng, MS8*, Hubert Chuang, MD PHD9* and Jason R. Westin, MD10

1Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
5Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
9U.T. M. D. Anderson Cancer Center, Houston, TX
10Department of Lymphoma and Myeloma, MD Anderson, Houston, TX

Daniela Hernandez, MD1, Carolina Velez-Mejia, MD2*, Joel E Michalek, PhD3*, Qianqian Liu, PhD4* and Adolfo Enrique Diaz Duque, MD, MSc5

1Internal Medicine Residency at Doctors Hospital at Renaissance, University of Texas Rio Grande Valley, McAllen, TX
2Internal Medicine, University of Texas Health at San Antonio, San Antonio, TX
3The University of Texas Health Science Center At San Antonio, San Antonio, TX
4Department of Epidemiology and Biostatistics, University of Texas Health at San Antonio, San Antonio, TX
5Hematology-Oncology Division, Mays Cancer Center UT Health San Antonio MD Anderson, San Antonio, TX

Michael J Buege, PharmD1, Phuong H Dao, PharmD1*, Esther Drill, DrPH2*, Andréa C LeVoir, PharmD1*, Terry Pak, PharmD1*, Tim J Peterson, PharmD1* and David J. Straus, MD3

1Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Thejus Jayakrishnan, MBBS1, Yazan Samhouri, MD2, Veli Bakalov, MD3, Zena Chahine, MD4*, Rodney E Wegner, MD5*, Cyrus Khan, MD3, Salman Fazal, MD2 and John Lister, MD2

1Department of Internal Medicine, Allegheny Helath Network, Pittsburgh, PA
2Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
3Allegheny Health Network Cancer Institute, Pittsburgh, PA
4Allegheny Health Network, Department of Internal Medicine, Pittsburgh, PA
5Division of Radiation Oncology, Allegheny Health Network Cancer Institute, Pittsburgh, PA

Cheng-Hong Tsai, MD, MSc1,2*, Feng Ming Tien, MD, MSc3*, Hsin-An Hou, MD, PhD1*, Jia-Hau Liu, MD3*, Shang-Ju Wu, MD, PhD1*, Yu-Wen Wang, MSc.4*, Chien-Chin Lin, MD5*, Bor-Sheng Ko, MD, PhD1*, Wen-Chien Chou, MD, PhD1, Yun-Chu Lin, MD3*, Chieh-Lung Cheng, MD1*, Li-Chun Lu, MD, PhD6*, Sung-Hsin Kuo, MD, PhD6*, Ruey-Long Hong, MD, PhD6*, Tai-Chung Huang, MD, PhD1* and Ming Yao, MD1*

1Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
2Genome and Systems Biology Degree Program, National Taiwan University, Taipei, Taiwan
3National Taiwan University Cancer Center, Taipei, Taiwan
4Department of pharmacy, National Taiwan University Hospital, Taiepi, Taiwan
5Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
6Department of oncology, National Taiwan University Hospital, Taipei, Taiwan

Annalisa Chiappella1, Anna Dodero1*, Anna Guidetti2, Filippo Bagnoli, MD1*, Vanessa Aragona3*, Anna Maria Barbui, MD4*, Stefania Bramanti, MD5*, Matteo Giovanni Carrabba, MD6*, Federica Sorà, MD7*, Pierluigi Zinzani, Prof, MD8, Chiara Monfrini3*, Cristiana Carniti3* and Paolo Corradini2

1Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
2Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori and Università degli Studi di Milano, Milano, Italy
3Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
4Division of Hematology and Stem Cell Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy, Italy
5Division of Hematology and Stem Cell Transplantation, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy
6Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
7Institute of Hematology, Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, ROMA, Italy
8Division of Hematology, Institute of Hematology “Seràgnoli" and University of Bologna, Bologna, Italy

Yuedan Chen*, Xuefei Sun*, Xueyan Bai*, Qu Cui, MD, PhD*, Ruixian Xing, MD, PhD* and Yuanbo Liu, MD, PhD*

Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

Qunling Zhang1*, Jichuan Wu2*, Juan J. Gu3, Yizhen Liu1*, Zuguang Xia1*, Lan Wang2*, Xiaonan Hong1* and Junning Cao, MD1*

1Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China
2CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
3Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY

Sanjal H Desai, MD1, Mansi Chaturvedi1*, Rumaisa Hameed1*, Valentina Baez Sosa, MD2 and Aarthi Shenoy, MD2

1Medstar Washington Hospital Center, Washington, DC
2MedStar Washington Hospital Center, Washington, DC

Cesar Gentille Sanchez, MD1, Ethan Burns, MD1*, Ibrahim Muhsen, MD2*, Humaira Sarfraz, MD2*, Carlo Guerrero, MD1*, John T Rogers, MD3*, Matthew D Cykowski, MD3*, Joe Ensor, PhD4*, Kirk Heyne, MD1*, Jorge G. Darcourt, MD5*, Jasleen K. Randhawa, MD6, Shilpan S. Shah, MD1 and Sai Ravi Kiran Pingali, MD4

1Houston Methodist Cancer Center, Houston, TX
2Department of Internal Medicine, Houston Methodist Hospital, Houston, TX
3Department of Pathology, Houston Methodist Hospital, Houston, TX
4Houston Methodist Cancer Center, HOUSTON, TX
56445 Main St - Outpatient center, 24th floor, Houston Methodist Cancer Center, Houston, TX
6Houston Methodist Cancer Center, Houston

Uri Greenbaum, MD1*, Paolo Strati, MD2, Rima M. Saliba, PhD1*, Janet Torres1*, Gabriela Rondon1, Yago Nieto, MD1, Chitra Hosing, MD1, Samer A. Srour, MD, MS3, Jason Westin, MD4, Luis Fayad5, Hun Ju Lee, MD4, Swaminathan P Iyer, MD6, Loretta J. Nastoupil, MD7, Simrit Parmar, M.D., MSCI8, Maria Alma Rodriguez, MD4*, Felipe Samaniego, MD4, Raphael Eric Steiner, MD4, Michael Wang, MD9, Chelsea C. Pinnix, MD, PhD10*, Christopher Flowers, MD, MS4, Sudhakar Tummala, MD11*, Jeremy Ramdial, MD1, Fevzi F. Yalniz1, Misha Hawkins12*, Katayoun Rezvani, MD, PhD1, Richard E. Champlin, MD1, Elizabeth J. Shpall, MD1, Sattva S. Neelapu, MD4, Partow Kebriaei, MD1 and Sairah Ahmed, MD13

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
3Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
7The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX
10Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
11Dept of Neuro-oncology, UT MD Anderson Cancer Center, Houston, TX
12Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
13Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH